Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia.
نویسنده
چکیده
Cardiovascular medicine has a sound evidence base upon which health professionals can base their interventions to modify risk among the British public. For primary prevention of cardiovascular disease, however, while there is considerable evidence on what to do, data are limited on how the evidence should be implemented in practice. The challenge will be to learn by experience which interventions directed at reducing blood pressure and lipids levels work best in different settings. There is a need to structure care to identify individuals who are at risk. Current targets are explicit and achievable for both hypertension and lipids. Effective treatment is likely to require multiple drug treatment.
منابع مشابه
Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab).
OBJECTIVE To measure the prevalence of untreated hypertension in Australian adults, and examine the associations with clinical and lifestyle factors. DESIGN AusDiab, a cross-sectional survey conducted between May 1999 and December 2000, involved participants from 42 randomly selected census districts throughout Australia. PARTICIPANTS Of 20 347 eligible people aged >or= 25 years who complet...
متن کاملObstructive sleep apnea and the severity of coronary artery disease
Background: It has been implicated that obstructive sleep apnea (OSA) is associated with increased risk of cardiovascular disease including stroke, myocardial infarction, coronary artery disease (CAD) and hypertension. The aim of this study was to investigate the correlation between OSA and severity of atherosclerosis assessed by angiography. Methods: This study included 337 patients ...
متن کاملAntecedant risk factors and their control in young patients with a first myocardial infarction.
INTRODUCTION Identifying and controlling cardiovascular risk factors at an early age may prevent cases of young myocardial infarction (MI). We studied age-related differences in the cumulative incidence of risk factors and the adequacy of primary prevention by surveying 1,556 patients with a first MI admitted to a tertiary hospital in Singapore. METHODS This is a single centre registry-based ...
متن کاملShould statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial.
Clinical trials demonstrate that HMGCoA reductase inhibitors reduce the risk of first cardiovascular events. However, better screening methods are needed in primary prevention to detect high risk individuals for whom the number needed to treat is small enough to make prophylactic statin therapy cost-effective. Although LDL screening improves cost-effectiveness of statins in some primary prevent...
متن کاملInvited Comment Inflammation modifies lipid-mediated renal injury
Clinical findings in humans suggest, and experimental studies in animal models demonstrate, that dyslipidaemia can lead to disease progression and glomerulosclerosis [1,2]. Thus, it has been established that cholesterol supplementation of the diets of several animal species leads to focal and segmental glomerulosclerosis (FSGS) [3–7] and foam cells and lipid deposits are found in focal segmenta...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Heart
دوره 90 Suppl 4 شماره
صفحات -
تاریخ انتشار 2004